Related references
Note: Only part of the references are listed.Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Alvin W. T. Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Aristolochic Acid in the Etiology of Renal Cell Carcinoma
Margaret L. Hoang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan
Yi-Chun Chen et al.
KIDNEY INTERNATIONAL (2015)
13-year nationwide cohort study of chronic kidney disease risk among treatment-naive patients with chronic hepatitis B in Taiwan
Yi-Chun Chen et al.
BMC NEPHROLOGY (2015)
Synergism Between Obesity and Alcohol in Increasing the Risk of Hepatocellular Carcinoma: A Prospective Cohort Study
Rohit Loomba et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy A Narrative Review
M. Refik Goekmen et al.
ANNALS OF INTERNAL MEDICINE (2013)
Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
Chung-Hsin Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Occupational Exposure to Herbs Containing Aristolochic Acids Increases the Risk of Urothelial Carcinoma in Chinese Herbalists
Hsiao-Yu Yang et al.
JOURNAL OF UROLOGY (2013)
Second primary cancers in patients with hepatocellular carcinoma: a nationwide cohort study in Taiwan
Wen-Chieh Wu et al.
LIVER INTERNATIONAL (2013)
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Song Ling Poon et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
High Incidence of Hepatocellular Carcinoma in ESRD Patients: Caused by High Hepatitis Rate or oUremia'? A Population-based Study
Jyh-Chang Hwang et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma
Jian Huang et al.
NATURE GENETICS (2012)
Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts
Victoria S. Sidorenko et al.
NUCLEIC ACIDS RESEARCH (2012)
Aristolochic acid-associated urothelial cancer in Taiwan
Chung-Hsin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Increased Risks of Upper Tract Urothelial Carcinoma in Male and Female Chinese Herbalists
Hsiao-Yu Yang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2011)
Occupational kidney disease among Chinese herbalists exposed to herbs containing aristolochic acids
Hsiao-Yu Yang et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2011)
Risks of Kidney Failure Associated With Consumption of Herbal Products Containing Mu Tong or Fangchi: A Population-Based Case-Control Study
Ming-Nan Lai et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk
Ming-Nan Lai et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Aflatoxin B1 Exposure, Hepatitis B Virus Infection, and Hepatocellular Carcinoma in Taiwan
Hui-Chen Wu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Increased Mortality Risk for Cancers of the Kidney and Other Urinary Organs among Chinese Herbalists
Hsiao-Yu Yang et al.
JOURNAL OF EPIDEMIOLOGY (2009)
Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid
Ming-Nan Lai et al.
NEPHROLOGY (2009)
Frequency and pattern of Chinese herbal medicine prescriptions for chronic hepatitis in Taiwan
Fang-Pey Chen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003
Shu-Ching Hsieh et al.
Chinese Medicine (2008)
DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver
Nan Mei et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry
TT Jong et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2003)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
